Use of fibrin or fibrinogen for reducing lung tissue volume
CA 2382817 C · Owner: Aeris Therapeutics, Inc. · Inventors: Ingenito, Edward P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Devices, compositions, and methods comprising fibrin or fibrinogen for achieving , non-surgical lung volume reduction (e.g. bronchoscopic lung volume reduction (BLVR)) are , described. BLVR can be carried out by collapsing a region of the lung adhering one portion , of the collapsed region to another and promoting fibrosis in or around the adherent tissue.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 23, 2000 and granted October 8, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 23, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 23, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.